Catalyst Wire Dossier Catalyst Wire Dossier

EU-Avastin

bevacizumab · Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EU-Avastin, covering 2024-12-18 to 2024-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers [Phase 1]

See pricing